Jefferies Group LLC Arbutus Biopharma Corp Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.5 - $3.51 $35,250 - $49,491
-14,100 Closed
0 $0
Q1 2021

Sep 21, 2023
BUY
$3.14 - $4.84 $44,274 - $68,244
14,100 New
14,100 $46,000
Q1 2021

May 14, 2021
BUY
$3.14 - $4.84 $44,274 - $68,244
14,100 New
14,100 $47,000
Q2 2019

Aug 14, 2019
SELL
$1.46 - $4.44 $14,873 - $45,230
-10,187 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$3.41 - $4.57 $34,737 - $46,554
10,187 New
10,187 $36,000

Others Institutions Holding ABUS

# of Institutions
130
Shares Held
82.2M
Call Options Held
4.82M
Put Options Held
546K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $489M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email